RICHLAND, Wash., July 7, 2017 /PRNewswire/ -- IsoRay, Inc.
(NYSE MKT: ISR), a medical technology company and innovator in seed
brachytherapy and medical radioisotope applications for the
treatment of prostate, brain, lung, head and neck and gynecological
cancers, today announced the appointment of Mark Austin as Controller, Principal Accounting
and Financial Officer. Mr. Austin's appointment is effective as of
July 24, 2017.
Mark Austin, CPA, has over 8
years of broad accounting experience in roles of increasing
responsibility at KPMG. He has extensive experience and training in
all aspects of current accounting processes and procedures of
public technology companies. Most recently he was Senior Manager
for financial statement and internal control audits within the
technology industry sector for KPMG, including a number of software
and manufacturing companies and served as the Lead Manager of a
global public company account for KPMG. Mr. Austin received a BS in
Accounting from Santa Clara University,
Santa Clara, CA and his CPA in
2010.
Thomas LaVoy, Chairman and CEO
commented, "As a senior manager at a "BIG 4" accounting firm with
public company experience, Mark
Austin is the right person to fill this important role at
IsoRay at this key time in our development. With our new sales
strategies and renewed message of commitment to the brachytherapy
community gaining traction, combined with our active development of
Cesium-131 for other cancers, especially the brain, IsoRay will
benefit from Mark's financial experience and we welcome him to the
team."
"I'm excited to join the team at IsoRay and contribute to
strengthening their financial platform for future growth. I believe
that Cesium-131 has the capability to improve the lives of many
cancer patients and I look forward to being a part of that effort,"
said Mark Austin.
About IsoRay, Inc.
IsoRay, Inc., through its
subsidiary, IsoRay Medical, Inc. is the sole producer of Cesium-131
brachytherapy seeds, which are expanding brachytherapy options
throughout the body. Learn more about this
innovative Richland, Washington Company and explore the
many benefits and uses of Cesium-131 by
visiting www.isoray.com. Join us on Facebook/IsoRay. Follow us
on Twitter @IsoRay.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/isoray-announces-appointment-of-mark-austin-as-controller-principal-accounting-and-financial-officer-300484449.html
SOURCE IsoRay, Inc.